Proof of Usefulness Report

EzDx Technology Inc.

Analysis completed on 2/26/2026

+44
Proof of Usefulness Score
You're In Business

EzDx Technology Inc. appears to be a legitimate early-stage biotech entity with verifiable hardware products (EzDx WeD-1) and mobile apps for point-of-care diagnostics. However, the submission is critically undermined by hyperbolic and demonstrably false claims regarding traction (e.g., claiming 'most people have used my product' while app downloads are minimal). While the core technology (isothermal amplification) and real-world utility are promising, the confusion between revenue and market cap, combined with the lack of verifiable user data, results in a low score typical of early-stage projects with poor self-reporting.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+75.0
Audience Reach Impact+5.0
Technical Innovation+70.0
Evidence Of Traction+10.0
Market Timing Relevance+85.0
Functional Completeness+15.0
Subtotal+42
Usefulness Multiplierx1.05
Final Score+44

Project Details

Project URL
ezdxtech.com
Description
EzDx is dedicated to offering convenient diagnostic tools and services to everyone. Our goal is to create "3A diagnostic", that is, Accurate, Accessible, and Affordable. As trailblazers in IoT intelligent diagnostics, EzDx specializes in empowering individuals with nucleic acid at-home self-testing and lightning-fast on-site rapid tests, delivering precise results when time matters most. Our cutting-edge technology, which integrates the Internet of Things with smartphones, enables us to offer a range of diagnostic tests, including screening and confirmatory tests, to serve our community and the general public. EzDx provides a broad range of easy-to-use, portable diagnostic tools at affordable prices, all of which can deliver POCT results within 20 minutes. Our panels cover numerous pathogens related to various human diseases, including respiratory, gastrointestinal, and sexually transmitted diseases. Additionally, we offer diagnostic solutions for the health of animals and pets, as well as recreational genetic testing for ancestry and traits. Moreover, we are actively developing a line of products focused on liquid biopsy for cancer minimal residual disease (MRD) detection, using transferable technology and ideology.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline